May 2005
Volume 46, Issue 13
Free
ARVO Annual Meeting Abstract  |   May 2005
Treatment of Ischemic Central Retinal Vein Occlusion Macular Edema: Triamcinolone vs Triamcinolone With Vitrectomy
Author Affiliations & Notes
  • J.M. Colina–Luquez
    Retina, APEC, Mexico, Mexico
  • A. Pérez–Reguera
    Retina, APEC, Mexico, Mexico
  • A. Meza de Regil
    Retina, APEC, Mexico, Mexico
  • J.L. Guerrero–Naranjo
    Retina, APEC, Mexico, Mexico
  • H. Quiróz–Mercado
    Retina, APEC, Mexico, Mexico
  • C. Leizaola–Fernández
    Retina, APEC, Mexico, Mexico
  • Footnotes
    Commercial Relationships  J.M. Colina–Luquez, None; A. Pérez–Reguera, None; A. Meza de Regil, None; J.L. Guerrero–Naranjo, None; H. Quiróz–Mercado, None; C. Leizaola–Fernández, None.
  • Footnotes
    Support  None.
Investigative Ophthalmology & Visual Science May 2005, Vol.46, 5325. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      J.M. Colina–Luquez, A. Pérez–Reguera, A. Meza de Regil, J.L. Guerrero–Naranjo, H. Quiróz–Mercado, C. Leizaola–Fernández; Treatment of Ischemic Central Retinal Vein Occlusion Macular Edema: Triamcinolone vs Triamcinolone With Vitrectomy . Invest. Ophthalmol. Vis. Sci. 2005;46(13):5325.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Abstract: : Purpose: To compare the functional and anatomical outcomes of treating patients with ischemic central retinal vein occlusion using triamcinolone alone or triamcinolone with vitrectomy Methods: This is a prospective, longitudinal, investigational and comparative case series of patients with ischemic CRVO and visual acuity of <20/100. Patients were a signed to either receive intravitreal triamcinolone injection alone (group A=6) or to undergo vitrectomy with intravitreal triamcinolone (group B = 10). Visual acuity, flourecein angiografy (FAG), optical coherence tomography (OCT) measurement of the central foveal thickness, and multifocal ERG were done before and at 3 months after the intervention. Eyes with rubeosis or previous laser treatment were excluded Results: This is a prospective, longitudinal, investigational and comparative case series of patients with ischemic CRVO and visual acuity of <20/100. Patients were a signed to either receive intravitreal triamcinolone injection alone (group A=6) or to undergo vitrectomy with intravitreal triamcinolone (group B = 10). Visual acuity, flourecein angiografy (FAG), optical coherence tomography (OCT) measurement of the central foveal thickness, and multifocal ERG were done before and at 3 months after the intervention. Eyes with rubeosis or previous laser treatment were excluded Conclusions: Although we did not obtain a statistically significant difference between the two groups due to the limited number of patients, pars plana vitrectomy with triamcinolone acetonide for the treatment of ischemic CRVO appears to have a better functional and anatomical outcomes compared to triamcinolone injection alone with minimal complications.

Keywords: ischemia • retina 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×